CD25⁺ cell depletion does not improve lymphedema, decrease fibrosis, or augment lymphatic function. A. by Jamie C. Zampell (298073)

ZEBRA and BGLF5 decrease levels of GFP mRNA and protein; one point mutant of ZEBRA does not inhibit GFP expression. by Richard Park (547667)

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

Effects of decreased NSUN2 and METTL1 expression on 5-FU-treatment and heat stress and 5-FU. by Mayumi Okamoto (280005)

Decreased BK responsiveness of p38 activation is evident in both PS-1 and PS-2 FAD mutant AD fibroblasts. by Graziella Mendonsa (374346)

Increasing glucose (D-Glu) concentrations decreases TNF-mediated A20 protein up-regulation without affecting its transcriptional activation in SMC. by Gautam V. Shrikhande (227350)

Increasing glucose (D-Glu) concentrations decreases TNF-mediated A20 protein up-regulation without affecting its transcriptional activation in EC. by Gautam V. Shrikhande (227350)

Plasma from ATTR individuals presents a higher proteolytic activity. by Gonçalo da Costa (198731)

Inhibition of Wnt signaling pathway or absence of TSP1 decreases cellular <i>T</i>. <i>cruzi</i> infection. by Ashutosh Arun (2574559)

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Developmental delay of <i>rpS13/+</i> animals is not due to a decrease in ribosome numbers or reduced translation rates. by Lisa Patricia Deliu (13570709)

A decrease in the amount of HBV nucleocapsids occurs when there is overexpression of singly-spliced2.2 kb RNA <i>in vivo</i>. by Yi-Ling Wang (704612)

Fold change of TIL subsets in paired TNBCs (N = 12 pts including 10 prim-met, and 2 met-met specimens) using log2 ratio of metastatic versus primary TNBC (n = 10, ●) or second recu... by Ting-Fang He (5210948)

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

CyaA decreases the capacity of TLR-stimulated DCs to present soluble antigen to CD4⁺ T cells. by Irena Adkins (173166)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Decreased function of Nrf2 in the aging heart. by Sellamuthu S. Gounder (306106)

“…<p>(<b>A</b>) <b>Decreased nuclear translocation of Nrf2 is evident in the heart of aging mice.…”

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

S5 Fig - by Meihui Chen (1670020)